A detailed history of Granite Fo LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Granite Fo LLC holds 425 shares of ABT stock, worth $48,182. This represents 0.03% of its overall portfolio holdings.

Number of Shares
425
Holding current value
$48,182
% of portfolio
0.03%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$100.07 - $118.13 $42,529 - $50,205
425 New
425 $48.5 Million
Q1 2024

Sep 05, 2024

SELL
$109.52 - $120.96 $109,520 - $120,960
-1,000 Reduced 70.18%
425 $48 Million
Q3 2023

Sep 05, 2024

BUY
$95.53 - $114.62 $7,164 - $8,596
75 Added 5.56%
1,425 $138 Million
Q2 2023

Sep 05, 2024

SELL
$100.78 - $112.29 $100,780 - $112,290
-1,000 Reduced 42.55%
1,350 $147 Million
Q1 2023

Sep 05, 2024

BUY
$96.86 - $114.01 $217,450 - $255,952
2,245 Added 2138.1%
2,350 $260 Million
Q4 2022

Sep 05, 2024

BUY
$95.06 - $111.52 $9,981 - $11,709
105 New
105 $11.3 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $199B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Granite Fo LLC Portfolio

Follow Granite Fo LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Granite Fo LLC, based on Form 13F filings with the SEC.

News

Stay updated on Granite Fo LLC with notifications on news.